Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)

Hong Kong · Delayed Price · Currency is HKD

538.00

+5.00 (0.94%)

Aug 21, 2026, 4:08 PM HKT

HKG:6990 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,086	2,058	1,933	1,540	803.93	32.32
Revenue Growth	1.35%	6.46%	25.48%	91.62%	2387.26%	-
Gross Profit	1,556	1,479	1,274	759.19	526.8	9.25
Operating Income	2.99	-419.57	-279.22	-453.7	-393.95	-795.24
Net Income	151.21	-381.97	-266.77	-522.21	-548.1	-822.55
Earnings Per Share	0.65	-1.66	-1.20	-2.84	-5.74	-8.90
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
The PRC	571.2	92.65	7.54	56.49	20.39
The United States of America	1,315	1,840	1,528	730.04	-
Switzerland	168.69	-	-	-	-
Other Countries	3.31	-	4.73	17.41	11.94
Total	2,058	1,933	1,540	803.93	32.32

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	4,778	4,472	3,069	2,488	92.96	81.79
Total Debt	81.35	88.44	126.75	59.92	3,014	2,391
Net Cash (Debt)	4,696	4,383	2,942	2,428	-2,921	-2,309
Net Cash Growth	7.14%	48.99%	21.15%	-	-	-
Net Cash Per Share	20.13	19.01	13.27	13.22	-30.58	-24.98

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	531.69	-180.3	-429.77	59.56	-270.85	-485.94
Capital Expenditures	-110.89	-125.69	-77.46	-80.98	-33.66	-94.08
Free Cash Flow	420.8	-305.99	-507.23	-21.42	-304.51	-580.03
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	74.59%	71.86%	65.89%	49.28%	65.53%	28.62%
Operating Margin	0.14%	-20.39%	-14.45%	-29.45%	-49.00%	-2460.37%
Pretax Margin	3.25%	-17.29%	-7.37%	-30.36%	-70.57%	-2752.91%
Profit Margin	7.25%	-18.56%	-13.80%	-33.90%	-68.18%	-2544.86%
FCF Margin	20.17%	-14.87%	-26.24%	-1.39%	-37.88%	-1794.52%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	53.40	39.94	18.04	13.29	-	-